Indicator summary: Leaning bearish (1 bullish, 3 bearish, 1 neutral). As of 2026-10-15, the close was $81.93: 0.2% below the 50-day average and 7.4% below the 200-day average, which is falling. RSI (14) is 56, in its neutral range. MACD is bullish after a cross in the last 10 days. The stock sits 25% of the way up its 52-week range of $76.21 to $99.49, on 0.9x its 20-day average volume.
| Indicator | Reading | Read |
|---|---|---|
| 50-day average | $82.08 | Price 0.2% below |
| 200-day average | $88.47 | Price 7.4% below, average falling |
| 50 vs 200-day | 50 below 200 | Death-cross alignment |
| RSI (14) | 56 | Neutral range |
| MACD (12, 26, 9) | -0.11 vs -0.74 | Bullish cross in the last 10 days |
| 52-week range | $76.21 to $99.49 | 25% of the way up the range |
| Volume vs 20-day average | 0.9x | Normal |
Base rates use SRE's own daily history since 1999; they describe the past, not a forecast.
As of 2026-10-15, SRE's 14-day RSI is 56, which is in the neutral range between 30 and 70.
No. SRE closed at $81.93 on 2026-10-15, 7.4% below its 200-day average of $88.47, which is falling. When it closed below its 200-day average (1,710 days), it was higher 63 trading days later 74% of the time, median +5.6%.
No. SRE closed at $81.93 on 2026-10-15, 0.2% below its 50-day average of $82.08. When it closed below its 50-day average (2,322 days), it was higher 63 trading days later 69% of the time, median +5.4%.
Yes, a bullish cross within the last 10 trading days. As of 2026-10-15 the MACD line is -0.11 against a signal line of -0.74, so MACD is bullish.
No. At $81.93 it sits 25% of the way up its 52-week range of $76.21 to $99.49, 17.7% below the high.
Leaning bearish: 1 of 5 indicators are bullish and 3 bearish as of 2026-10-15 (the 50 and 200-day averages, their alignment, RSI and MACD). A rating summarises the chart; it is not a recommendation.
ŷRobot chart signal: Buy, from the chart signal model.
SRE analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.